Literature DB >> 26460302

Hitting the Target in BRAF-Mutant Colorectal Cancer.

Ankur K Nagaraja1, Adam J Bass2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26460302     DOI: 10.1200/JCO.2015.63.7793

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Chemotherapeutic drug selectivity between wild-type and mutant BRaf kinases in colon cancer.

Authors:  Jianchun Zhang; Tao Ji
Journal:  J Mol Model       Date:  2016-12-05       Impact factor: 1.810

2.  A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.

Authors:  Konrad Klinghammer; James Keller; Jonathan George; Jens Hoffmann; Edward L Chan; Michael J Hayman
Journal:  Int J Cancer       Date:  2017-10-04       Impact factor: 7.396

Review 3.  Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.

Authors:  John Paul Shen; Trey Ideker
Journal:  J Mol Biol       Date:  2018-06-20       Impact factor: 5.469

Review 4.  Artificial intelligence, molecular subtyping, biomarkers, and precision oncology.

Authors:  John Paul Shen
Journal:  Emerg Top Life Sci       Date:  2021-12-21

Review 5.  Cancer subtypes classification using long non-coding RNA.

Authors:  Ronan Flippot; Gabriel G Malouf; Xiaoping Su; Roger Mouawad; Jean-Philippe Spano; David Khayat
Journal:  Oncotarget       Date:  2016-08-16

6.  Connecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human In Vitro Tissue Models with Boolean In Silico Models.

Authors:  Florentin Baur; Sarah L Nietzer; Meik Kunz; Fabian Saal; Julian Jeromin; Stephanie Matschos; Michael Linnebacher; Heike Walles; Thomas Dandekar; Gudrun Dandekar
Journal:  Cancers (Basel)       Date:  2019-12-20       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.